Expected deviation in sample size calculation [Power / Sample Size]

posted by Dr_Dan  – Germany, 2011-06-10 10:51 (5488 d 02:28 ago) – Posting: # 7100
Views: 7,001

Dear Skar
What do you mean by "expected deviation"? True difference in formulation (µT/µR) or difference in number of subjects needed to demonstrate BE with a specific power and number of enrolled subjects (drop out reserve)? In both cases the answer is: it depends....
In general you calculate your sample size with a formulation difference < 5%. Assuming a greater difference will tell an assessor that you have information showing that your formulation is borderline bioequivalent (= bad formulation that can only fit in the BE acceptance range if the study is overpowered).
To calculate the drop out reserve you need to know the adverse event profile of the drug and the compliance of the subjects.
I hope this helps.
Kind regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
160 visitors (0 registered, 160 guests [including 17 identified bots]).
Forum time: 13:19 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends.    Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5